Clinical Trial for Low Grade (Grade II) Glioma Patients Now Open and Accepting Patients
Miles For Hope announced today that the brain tumor vaccine clinical trial, Optimizing Dendritic Cell Vaccination for Low Grade Glioma Patients, is now…
Clinical Trial